The Annual General Meeting was held in accordance with the published agenda (announcement dated March 16, 2011).
The General Meeting took note of the report on the Company’s activities and adopted the Annual Report 2010. Also, the General Meeting adopted the proposed decision on use of profit/loss.
All board members were up for election. Carsten Lønfeldt, Peter Nordkild, Niels T. Foged and Marianne Weile were re-elected. After the meeting the Board constituted itself with Carsten Lønfeldt as chairman.
Deloitte was re-elected auditor for BioPorto A/S.
All proposals from the Board of Directors in the agenda’s item 5 as mentioned in the summoning were carried unanimously, yet with a change of the approval and authorization of item 5a and 5b following a proposal from the Board. Thus, the remuneration policy states that the Board does not participate in the issue of warrants and that the authorization to issue warrants only encompass the issue of warrants to executive management and employees. The proposals were carried with the mentioned changes:
- Approval of the company’s remuneration policy
- Authorization of the Board of Directors to issue warrants for shares in the company of nominal value to a maximum of DKK 5.000.000 and delete the current authorization in article 18 of the Company Articles.
- Authorization of the Board of Directors to, for a period of 18 months after the annual general meeting, repurchase up to 10% of the company’s share capital at any given time.
- Inclusion of an age limit for board members in the Company Articles.
Gentofte, April 7, 2011
The Board of Directors
BioPorto A/S
Further information:
Christina Thomsen, Investor Relations
Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com
